Rachel Flehinger
Articles by Rachel Flehinger
| 3 min read
MANF Therapeutics restarts IND-enabling work in light of new results
| 3 min read
Melinta Therapeutics seeks to move investigational pyrrolocytosine compounds into clinical stage
| 3 min read
A pair of new deals with Daiichi and Takeda help move Thermo’s technology forward
| 3 min read
Sutro Biopharma advances STRO-001 and STRO-002 into the clinic against multiple cancer types
| 3 min read
Scripps scientists use 3D spheroids to better test cancer drugs’ efficacy
| 3 min read
Combination of immune agonists may fight one of the fastest-moving and deadliest of cancers
| 3 min read
QIAGEN acquires molecular diagnostics company STAT-Dx and its multiplex technologies
| 2 min read
With half of CAR-T studies in China, Cesca looks to capitalize on market potential with CDMO expansion
| 3 min read
CD133 revealed as a potential target for encouraging kidney repair
| 3 min read
Kinase inhibitor may prove useful in treating rare genetic disease
Page 1 of 6 - 81 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Enhancing immune cell profiling with digital technologies
Software innovations help researchers decode immune complexity in cancer.
Preparing data for AI/ML predictive modeling
Mastering data preparation is key to harnessing the full potential of advanced computational tools.
A Technology Guide for CRISPR Screening
Emerging CRISPR screening methods are shaping what’s possible in drug development and precision medicine.
